跳至主要内容
临床试验/NCT01017627
NCT01017627Unknown不适用

A Case Controlled Study to Determine the Impact of Adherence to Anemia Management Policy on Repeat Hospitalization in ESRD

Fresenius Medical Care North America42 个研究点 分布在 1 个国家目标入组 1,500 人开始时间: 2009年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
1,500
试验地点
42
主要终点
composite of death or repeat hospitalization within the 30 days after discharge from a previous hospitalization

研究概览

简要总结

The investigators hypothesize that the post-hospitalized patient status is characterized by subacute and reversible metabolic and hematological changes that, if addressed and treated in a timely manner, would result in a reduced risk for repeat hospitalization. Consequently, a structured quality improvement program, focused on increasing adherence to company wide anemia management policies (ie hemoglobin monitoring within the first 3-5 days post-hospitalization, followed by an appropriate EPO dose modification within the 7 days post-hospitalization), will significantly decrease the risk of hospital re-admission in the 30 days after discharge.

详细描述

The post-hospitalization quality improvement project will be piloted across 30 Fresenius clinics. Targeted enrollment of 1500 episodes of hospitalization in which the patient returns after discharge to resume outpatient dialysis.

Patient outcomes will be followed for up to 30 days from the time of discharge from hospital.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •resumption of routine outpatient chronic hemodialysis within three days of discharge from hospital admission
  • •enrolled in a facility-based anemia management program

排除标准

  • •enrolled in hospice
  • •previous hospitalization within the past 30 days (ie. patients discharged from a repeat hospitalization)
  • •anticipated discharge from the outpatient dialysis facility within 30 days (ie anticipated transfer to another facility or hospice)

研究组 & 干预措施

Early anemia management

Other

Upon return to the dialysis unit following hospitalization, patients will be immediately identified and have immediate implementation of the unit anemia protocol rather than waiting for the next regularly scheduled unit labs and regular follow-up. Thus, labs will be obtained within the first 3-7 days following hospitalization and appropriate titration of Epo and iron medications within the 7 days after discharge from hospital and under the direction of the pre-specified algorithm used in the patient's facility; all drug dosing will comply with package insert instructions

干预措施: Early anemia diagnosis and treatment (Other)

case control

Other

Each case will be "data-matched" to an intra-facility (primary control), and then an inter-facility (validation control) control patient. Matching criteria will be by age, gender, diabetic status, attending nephrologist, length of hospitalization stay, and hospital discharge date (to minimize the difference in the date between the case and control). These patients did not have early intervention but followed the usual practice of waiting for the next regularly scheduled dialysis unit labs with anemia management to follow using the regular unit algorithm.

干预措施: No change from normal routine (Other)

结局指标

主要结局

composite of death or repeat hospitalization within the 30 days after discharge from a previous hospitalization

时间窗: one year to accumulate 1500 hospitalizations

次要结局

  • hemoglobin, transferrin saturation, albumin, white blood cell count, and C-reactive protein* levels measured in the period following hospitalization and change relative to values measured prior to hospitalization (where available).(one year to accumulate 1500 hospitalizations)

研究者

申办方类型
Industry

研究点 (42)

Loading locations...

相似试验